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Edited by Veli-Pekka LehtoAbstract We recently identiﬁed receptor-mediated endocytosis
8 (RME-8), a DnaJ domain protein localized to endosomes.
We now demonstrate that RME-8 depletion leads to decreased
levels of epidermal growth factor receptor (EGFR) without inﬂu-
encing receptors that primarily recycle to the plasma membrane.
Decreases in EGFR are detected at both surface and intracellu-
lar pools and result from increased rates of EGFR degradation.
Interestingly, RME-8 depletion also decreases EGFR levels in
breast cancer cell lines in which overexpression of the EGFR
family member ErbB2 has been shown to protect EGFR from
degradation. These data implicate RME-8 in sorting decisions
inﬂuencing EGFR at the level of endosomes and point to
RME-8 as a potential regulatory target in ErbB2-positive breast
cancers.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Clathrin-coated vesicles (CCVs) are the major carriers for
endocytic cargo. Following their ﬁssion from the plasma mem-
brane, CCVs uncoat and fuse with early endosomes, the initial
sorting station in the endocytic pathway [1]. Cargo such as the
transferrin receptor (TfR), which predominantly recycle, segre-
gate into thin membrane tubules that bud oﬀ endosomes for
transport back to the plasma membrane [1] whereas the
remaining early endosome develops into late endosomes, pos-
sibly through a series of fusion and ﬁssion events coupled with
retrograde ﬂow of early endosome resident proteins [2]. Cargo,
such as the epidermal growth factor receptor (EGFR), which
are predominantly degraded undergo inward invagination into
the lumen of the endosome during the maturation process
leading to multivesicular bodies (MVBs) that fuse with lyso-
somes for degradation [1,3].
The process by which cargo is targeted for inward invagina-
tion is complex and involves four protein assemblies on endo-
somal membranes referred to as endosomal sorting complex
required for transport (ESCRT) 0 through ESCRT III [4].
Receptors targeted for degradation, such as EGFR are tagged
with ubiquitin [5], which is recognized by Hrs within the ESC-
RT 0 complex [4]. The ubiquitinated cargo is then transferred*Corresponding author. Fax: +1 514 398 8106.
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doi:10.1016/j.febslet.2008.02.042to the other ESCRT complexes and is eventually coupled to
the machinery for inward budding [4]. Hrs binds to phospha-
tidylinositol-3-P, which is enriched on early endosomes, and
also binds clathrin, helping recruit clathrin to early endosome
membranes where it forms a poorly deﬁned bilayered clathrin
coat that in turn stabilizes Hrs and restricts it to the regions of
the endosome where inward invagination occurs [6,7]. Like
other clathrin coats [8], the bilayered coat undergoes a dy-
namic exchange with the cytosol, ﬂuctuating between assem-
bled (membrane associated) and disassembled (cytosolic)
states and interestingly, the degree of association of the Hrs-
rich coat with the membrane is a critical factor in recruiting
ubiquitinated cargo for eventual degradation [7].
We recently identiﬁed and characterized the mammalian
form of receptor-mediated endocytosis 8 (RME-8) [9], a DnaJ
domain-containing protein originally identiﬁed in a screen for
endocytic defects in Caenorhabditis elegans [10]. As for RME-8
in invertebrates and plants, mammalian RME-8 co-localizes
with multiple markers of the endosomal system including
internalized transferrin and EGF and the early endosomal
marker EEA1 [9–12]. Through its DnaJ domain, RME-8 binds
the chaperone Hsc70 [9,11], which regulates uncoating of
CCVs [13–15] and which is also involved, in an unknown man-
ner, in regulating receptor traﬃcking at endosomes [16]. We
now use a loss of function approach to demonstrate that
RME-8 regulates the cellular levels of EGFR by contributing
to the control of EGFR endosomal traﬃcking and degrada-
tion.2. Materials and methods
2.1. Antibodies
A polyclonal RME-8 antibody was previously described [9]. Mouse
monoclonal antibodies against the following proteins were purchased
from the indicated commercial sources: Na+/K+ ATPase, Upstate Bio-
technology (Lake Placid, NY); EGFR, Santa Cruz Biotechnology
(Santa Cruz, CA); and TfR, Zymed Laboratories Inc. (South San
Francisco, CA). Polyclonal antibodies against EGFR, LDLR, and
ErbB2 were from Santa Cruz Biotechnology, Fitzgerald Industries
International Inc. (Concord, MA), and Abcam (Cambridge, MA),
respectively. Polyclonal antibody against insulin receptor was a gift
of Dr. John Bergeron (McGill University, Montreal, Canada). Dr.
William Muller (McGill University, Montreal, Canada) kindly pro-
vided SKBR3 and BT474 cell lines.
2.2. Analysis of protein levels following siRNA-mediated KD of RME-8
RME-8 siRNA and transfection procedures were previously de-
scribed [9]. Brieﬂy, COS-7, HeLa, SKBR3, or BT474 cells were plated
in DMEM without antibiotics at 60% conﬂuency. At 24 h post-plating,
cells were transfected once with 80 nM siRNA using Lipofectamine
2000 (Invitrogen) with the transfection repeated 24 h later. Experi-
ments were performed 72 h after the ﬁrst transfection for COS-7 andblished by Elsevier B.V. All rights reserved.
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Western blot, cells were scrapped in RIPA buﬀer (10 mM HEPES, pH
7.4, 150 mM NaCl, 1% Triton X-100 and 0.1% SDS supplemented
with 0.83 mM benzamidine, 0.23 mM phenylmethylsulfonyl ﬂuoride,
0.5 lg/ml aprotinin and 0.5 lg/ml leupeptin) and centrifuged for
10 min at 800 · g. Proteins from equal protein aliquots of the superna-
tant were separated by SDS–PAGE, analyzed by Western Blot and
blot signals were quantiﬁed using NIH ImageJ software.
2.3. EGFR immunoﬂuorescence and FACS analysis
For EGFR immunoﬂuorescence, COS-7 cells were plated on poly-L-
lysine coverslips. One set of cells (surface EGFR) was cooled to 4 C,
washed in cold PBS, incubated for 3 h on ice with an antibody against
EGFR, ﬁxed for 20 min with 3% ice-cold paraformaldehyde (PFA)
and incubated with a CY3-conjugated secondary antibody. A second
set of cells (total EGFR) was ﬁrst ﬁxed in 3% PFA, pre-permeabilized
for 10 min with 0.05% saponin, incubated for 3 h with EGFR antibody
diluted in 0.05% saponin, followed by detection using a CY3-conju-
gated secondary antibody. Immunoﬂuorescence images were collected
using a Zeiss 510 laser scanning confocal microscope and the acquisi-
tion settings were kept constant between mock and siRNA treated
cells.
Fluorescence activated cell sorting analysis (FACS) was performed
using FACScan with data analyzed using the CellQuantPro program
(BD Biosciences). COS-7 cells, mock transfected or transfected with
RME-8 siRNA were ﬁrst cooled on ice. One set of cells, used to assess
the level of surface EGFR, was incubated with EGFR antibody at 4 C
for 3 h, washed with cold PBS, incubated with CY2-conjugated
secondary antibody at 4 C for 1 h and resuspended in cold PBS. A
second set of cells, used to assess total EGFR level, was pre-permeabi-
lized with 0.05% saponin, incubated with EGFR antibody diluted in
0.05% saponin for 3 h at 4 C, washed with cold PBS, incubated with
CY2-conjugated secondary antibody at 4 C for 1 h and resuspended
in cold PBS.
2.4. EGFR degradation assay
Mock and RME-8 KD COS-7 cells were serum-starved O/N and
then incubated for 1 h at 37 C in cysteine/methionine-free DMEM
(Invitrogen). Cells were then pulsed for 2 h at 20 C with 0.1 mCi/
ml Pro-Mix [35S] (Amersham Biosciences), washed, and chased at
37 C for 0, 2, 4, and 6 h in DMEM containing methionine0
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Fig. 1. RME-8 KD decreases steady-state levels of EGFR. (A) COS-7 or He
72 h following transfection, cell lysates were prepared and processed for We
blots as in A were quantiﬁed. The bars represent means ± S.E.M. (n = betwee
for RME-8 and EGFR (paired t-test, P < 0.001).(0.06 mg/ml), cysteine (0.1 mg/ml), cycloheximide (25 lg/ml), and
EGF (100 ng/ml). At each time point, the cells were washed, lysed
(50 mM TRIS pH 7.4, 150 mM NaCl, 10% glycerol, 5 mM EDTA,
1% Triton X-100), spun at 20,000 · g max and equal protein aliquots
of the supernatants were added to 25 ll protein-G beads (Amersham
Biosciences) and 10 ll of EGFR monoclonal antibody in order to
immunoprecipitate EGFR. Immunoprecipitated proteins were sepa-
rated on SDS–PAGE and processed for autoradiography using a
STORM PhosphorImager (Amersham Biosciences) followed by expo-
sure to X-ray ﬁlm. Quantiﬁcation was performed using ImageQuant
software.3. Results and discussion
We previously established conditions using small inhibitory
RNA (siRNA) to knock down (KD) RME-8 in cultured cells
without inﬂuencing the levels of multiple control proteins [9].
During these studies, we noticed that the steady-state level of
endogenous EGFR was decreased following loss of RME-8
function in COS-7 cells [9]. We thus sought to further examine
this intriguing observation. Importantly, the decrease in
EGFR levels resulting from RME-8 KD is not limited to
COS-7 cells and is also seen in HeLa cells (Fig. 1A). EGFR
is decreased by 46.6% and 65.5% of that in control in COS-7
and HeLa, respectively (Fig. 1B). The decrease in total level
of EGFR was also readily detectable by immunoﬂuorescence
when using an EGFR antibody on ﬁxed and permeabilized
COS-7 cells (Fig. 2A). This decrease appeared to be roughly
proportional to a decrease in surface levels as determined by
adding the EGFR antibody (which recognizes the extracellular
domain) to live cells at 4 C prior to washing and ﬁxation
(Fig. 2A). To quantify this observation, we performed FACS
to measure total versus surface levels of EGFR in control
and RME-8 KD conditions. We detected a similar decrease
for total and surface pools, 35.5% and 39.3%, respectively8 EGFR TfR InsR
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Fig. 2. EGFR is decreased at the surface proportional to the total decrease. (A) COS-7 cells, mock transfected or transfected with RME-8 siRNA,
were ﬁxed, permeabilized and stained with an antibody against EGFR (total EGFR). Alternatively, live cells, held at 4 C, were incubated with the
EGFR antibody before washing and ﬁxation (surface EGFR). (B) COS-7 cells, mock transfected or transfected with RME-8 siRNA were incubated
with EGFR antibody with (total) or without (surface) permeabilization as described in Section 2 and were then resuspended and subjected to a FACS
analysis. Signiﬁcant decreases in EGFR were detected for both total and surface pools following RME-8 KD (paired t-test, P < 0.01 for total and
P < 0.001 for surface, n = 6 for each).
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by Western blot (Fig. 1). Thus, the decrease in EGFR levels
does not represent a selective loss of the surface pool of recep-
tor.
In contrast to EGFR, the levels of TfR and insulin receptor
(InsR) in COS-7 and HeLa cells and the level of low-density
lipoprotein receptor (LDLR) in HeLa cells (LDLR is not de-
tected in COS-7 cells with the antibody employed) are unal-
tered following RME-8 KD (Fig. 1A/B). Na+/K+-ATPase is
used as a loading control (Fig. 1A). Following constitutive
clathrin-mediated endocytosis, TfR, InsR, and LDLR enter
early endosomes and are targeted primarily to recycling path-
ways for return to the plasma membrane [17–19]. Thus, RME-
8 KD does not appear to inﬂuence the constitutive recycling
pathway but does alter the levels of EGFR, which is targeted
from early endosomes to late endosomes/lysosomes [20]. In
fact, EGFR undergoes constitutive endocytosis at a rate of
1–2%/min [21]. Thus, it is possible that RME-8 normally plays
a negative regulatory role in traﬃcking of EGFR to the degra-
dative pathway and that loss of RME-8 function allows more
EGFR to enter this pathway during the course of the KD lead-
ing to decreased steady-state levels. However, it is also conceiv-
able that RME-8 KD leads to decreased EGFR by decreasing
mRNA levels or by altering the rate of receptor synthesis.
To examine these possibilities, we performed metabolic
labelling experiments. Cells were ﬁrst pulsed with [35S]cys-
teine/methionine to label newly synthesized proteins and cell
lysates were subjected to immunoprecipitation analysis with
an EGFR antibody. Equivalent amounts of newly synthesized
EGFR were immunoprecipitated under control and KD con-
ditions (Fig. 3A), strongly suggesting that RME-8 KD does
not inﬂuence EGFR synthesis. We next chased the metaboli-
cally labelled cells for various time points in the presence of
100 ng/ml EGF. Importantly, over a time course of 6 h, the
amount of EGFR decreased more rapidly in RME-8 KD cells
than in control (Fig. 3B). Quantiﬁcation of multiple experi-ments conﬁrmed that RME-8 KD signiﬁcantly increases the
rate of EGFR degradation (Fig. 3C). Thus, we hypothesize
that RME-8 is a negative regulator of EGFR traﬃcking to
the degradative pathway and as a consequence, KD of
RME-8 increases degradation rates leading to a decrease in
receptor steady-state levels. A role for RME-8 in the regula-
tion of degradative traﬃcking at the level of endosomes is con-
sistent with the recent demonstration that in plants, RME-8
functions in vesicle traﬃcking from MVBs to the lytic vacuole,
the plant equivalent of lysosomes [12].
Traﬃcking decisions regarding degradation versus recycling
have critical pathological implications. For example, although
EGFR is normally targeted for degradation following EGF
activation, overexpression of the EGFR family member ErbB2
leads to EGFR/ErbB2 heterodimers that are directed towards
the recycling pathway [22,23]. This leads to prolonged mito-
genic signaling downstream of EGFR and may explain why
ErbB2 overexpression is found in many carcinomas and corre-
lates with poor prognosis [23,24]. Since RME-8 KD enhances
EGFR degradation we sought to test if it could, at least in
part, overcome the ability of ErbB2 to prevent EGFR down
regulation with implications for ErbB2-positive cancers.
ErbB2 normally undergoes constitutive endocytosis and recy-
cling. Thus, we examined its steady-state levels in non-over-
expressing cells. In this set of experiments, EGFR is
decreased by 45.8% and 63.1% in COS-7 and HeLa cells,
respectively, following RME-8 KD, whereas in the same exper-
iments there is no signiﬁcant change in the levels of ErbB2
(Fig. 4A/B). Thus, consistent with earlier results, RME-8
KD does not inﬂuence the levels of a constitutively recycling
receptor.
We next turned to experiments in BT474 and SKBR3 human
breast cancer cells lines, which we obtained from Dr. William
Muller (McGill University). These cells overexpress ErbB2 and
have been used as a model to establish that ErbB2 overexpres-
sion leads to increased EGFR recycling [22]. Transfection with
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Fig. 3. RME-8 KD increases EGFR degradation rates. (A) COS-7 cells, mock transfected or transfected with RME-8 siRNA, were pulsed with
[35S]cysteine/methionine to label newly synthesized proteins. Soluble cell lysates were prepared for immunoprecipitation with an EGFR antibody and
immunoprecipitated proteins were subject to autoradiography. (B) Cells prepared as in A were subsequently chased for various time points, as
indicated, in regular media containing EGF before soluble cell lysates were prepared for immunoprecipitation with EGFR antibody, followed by
autoradiography. (C) The levels of EGFR as determined in B were quantiﬁed. The points represent means ± S.E.M., n = 4 for each condition.
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Fig. 4. RME-8 KD does not inﬂuence the levels of ErbB2. (A) COS-7 or HeLa cells were mock transfected or transfected with RME-8 siRNA. At
72 h following transfection, cell lysates were prepared and processed for Western blot with antibodies against the indicated proteins. (B) The EGFR
and ErbB2 Western blots from A were quantiﬁed. The bars represent means ± S.E.M. (n = 6 for each blot). Signiﬁcant diﬀerences were detected for
EGFR (paired t-test, P < 0.01).
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(Fig. 5A; 73.2% and 74.1% decrease in RME-8 in BT474 and
SKBR3 cells, respectively). Although this level of KD is some-
what less then that seen in COS-7 and HeLa (Fig. 1B), there
was still a signiﬁcant decrease in the levels of EGFR (37.3%
and 32.6% in BT474 and SKBR3, respectively; Fig. 5A/B; note
that the EGFR antibody employed in this study cross-reacts
with ErbB2 at high levels of ErbB2 expression). As for COS-
7 and HeLa cells, RME-8 KD did not inﬂuence the steady-state levels of ErbB2 in either breast cancer cell line
(Fig. 5A/B). Thus, although ErbB2 overexpression may be par-
tially protective of the decrease in EGFR levels caused by
RME-8 KD, to the large part, RME-8 KD is an eﬀective meth-
od to reduce EGFR levels even in the face of gross ErbB2
overexpression. These data suggest that RME-8 may be a valu-
able target in the treatment of ErbB2-positive breast cancers.
The mechanism by which RME-8 may function in endo-
somal traﬃcking and EGFR degradation is not currently
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Fig. 5. ErbB2 does not protect EGFR from degradation following RME-8 KD. (A) BT474 or SKBR3 breast cancer cells were mock transfected or
transfected with RME-8 siRNA. At 96 h following transfection, cell lysates were prepared and processed for Western blot with antibodies against the
indicated proteins. (B) The EGFR and ErbB2 Western blots from A were quantiﬁed. The bars represent means ± S.E.M. (n = 6 for each blot).
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with Hsc70 on endosomes to regulate the association of bilay-
ered clathrin coats with endosomal membranes. In fact, Hsc70
was previously implicated in traﬃcking decisions on early
endosomes [16]. Normally, RME-8/Hsc70 would disassemble
endosomal clathrin coats as part of the normal kinetic equilib-
rium of clathrin coats and Hrs between membranes and the
cytosol [7]. RME-8 KD would thus lead to increased associa-
tion of coats and Hrs with membranes. Ubiquitinated cargo
would have more binding sites on endosomes, which would in-
crease their targeting to ESCRTs, entry in MVBs and degrada-
tion. In fact, RME-8 KD cells have less CHC in the cytosol
with no overall change in CHC levels [9]. If this hypothesis
is correct, RME-8 could have a general inﬂuence on the traf-
ﬁcking of receptors that are targeted via ubiquitination to
the degradative pathway and in fact RME-8 KD decreases
the levels of the NGF receptor TrkA when transfected in cul-
tured cells (data not shown). Future studies will be directed to-
wards testing this hypothesis.Note added in proof
During the review of this paper, a study from Fujibayashi
et al. [25] was released indicating that RME-8 regulates mem-
brane traﬃcking through early endosomes.
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